Is HOOKIPA Pharma Inc. (HOOK) a Buy, Sell, or Hold?
OTC : HOOK
HOOKIPA Pharma Inc.
$1.15 USD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 11.96K
- Market Capitalization
- $14.4M
- P/E Ratio
- -0.71
- Dividend Yield
- 0.00%
- Price Target
- $3.00
- Year High
- $1.55
- Year Low
- $0.81
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.93
Industry, Sector & symbol
| Stock Exchange | OTC |
| CEO | Malte Peters |
| Industry | Biotechnology |
| Sector | Healthcare |
| Current Symbol | HOOK |
| CUSIP | 43906K209 |
| CIK | 0001760542 |
| Web | https://www.hookipapharma.com |
| Phone | 431 890 6360 |
| Currency | USD |
| Employees | 82 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.02 |
| Payout Ratio | 0.00 |
| Current Ratio | 3.93 |
| Quick Ratio | 3.93 |
| Cash Ratio | 2.60 |
Sales & Book Value
| Annual Sales | $9.7M |
| Price / Sales | 1.64 |
| Cash Flow | -0.56 |
| Price / Cash Flow | -2.03 |
| Price / Book | 0.51 |
Price Target and Rating
| Average Stock Price Forecast | $3.00 |
| High Stock Price Forecast | $3.00 |
| Low Stock Price Forecast | $3.00 |
| Forecast Upside/Downside | -61.67% |
| Consensus Rating | N/A |
| Rating Score(0-5) | 0 |
| Research Coverage | 9 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | -$1.09 |
| Trailing P/E Ratio | -0.71 |
| PEG Ratio | 0.01 |
| P/E Growth | 0.01 |
| Net Income | -$13.84M |
| Net Margin | -195.62% |
| Pretax Margin | -195.62% |
| Return on Equity | -54.85% |
| Return on Assets | -32.66% |
Financials Score
| AltmanZ Score | -13.42 |
| Piotroski Score | 2.00 |
| Working Capital | 38.52M |
| Total Assets | 52.71M |
| Ebit | -56.11M |
| Market Cap | 14.4M |
| Total Liabilities | 24.02M |
Poll Results
About HOOKIPA Pharma Inc. (OTC:HOOK) Stock
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company’s immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer. It is also developing HB-400 for the treatment of Hepatitis B that is in Phase I of clinical trial; ... and HB-500 for the treatment of Human Immunodeficiency Virus (HIV) that is in Phase I of clinical trial. The company has a collaboration and license agreement with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products for the treatment, cure, diagnosis, or prevention of the hepatitis B virus (HBV) and the HIV. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.
Frequently Asked Questions
-
What is the current HOOKIPA Pharma Inc. (HOOK) stock price?
-
HOOKIPA Pharma Inc.(OTC:HOOK) stock price is $1.15 in the last trading session. During the trading session, HOOK stock reached the peak price of $1.55 while $0.811 was the lowest point it dropped to. The percentage change in HOOK stock occurred in the recent session was 0.0% while the dollar amount for the price change in HOOK stock was $0.
-
HOOK's industry and sector of operation?
-
The OTC listed HOOK is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of HOOK?
-
Malte Peters | Chief Executive Officer, President & Director
Daniel D. Pinschewer | Co-Founder & Member of Scientific Advisory Board
Mark Winderlich | Chief Research & Development Officer
Mary Theresa Coelho | Executive Vice President, Chief Financial Officer & Director
| -
How many employees does HOOK have?
-
Number of HOOK employees currently stands at 82. HOOK operates from 350 Fifth Avenue, New York, NY 10118, US.
-
Link for HOOK official website?
-
Official Website of HOOK is: https://www.hookipapharma.com
-
How do I contact HOOK?
-
HOOK could be contacted at phone #431 890 6360 and can also be accessed through its website. HOOK operates from 350 Fifth Avenue, New York, NY 10118, US.
-
How many shares of HOOK are traded daily?
-
The average number of HOOK shares traded daily for last 3 months was 11.96K.
-
What is the market cap of HOOK currently?
-
The market value of HOOK currently stands at $14.4M with its latest stock price at $1.15